Low-Dose Lenalidomide Plus Cytarabine Induce Complete Remission That Can Be Predicted by Genetic Profiling in Elderly Acute Myeloid Leukemia Patients

Leukemia - United Kingdom
doi 10.1038/leu.2014.31
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cytarabine Dose for Acute Myeloid Leukemia

New England Journal of Medicine
Medicine
2011English

Randomized, Phase IIb Study of Low-Dose Cytarabine and Lintuzumab Versus Low-Dose Cytarabine and Placebo in Older Adults With Untreated Acute Myeloid Leukemia

Haematologica
Hematology
2012English

Persistent Molecular Remission of Refractory Acute Myeloid Leukemia With Inv(16)(p13.1q22) in an Elderly Patient Induced by Cytarabine Ocfosfate Hydrate

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2015English

High Dose Cytarabine Plus Gemtuzumab Ozogamicin for Patients With Relapsed or Refractory Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 19902

Leukemia Research
Cancer ResearchOncologyHematology
2011English

Therapy-Related Acute Non-Lymphocytic Leukemia(M2) With 7;11 Chromosome Translocation Induced Into Complete Remission by Low Dose Cytosine Arabinoside and Cytarabine Ocfosfate Therapy.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1994English

A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2016English

A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Venetoclax Plus Decitabine Induced Complete Remission With Molecular Response in Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplantation

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy